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on 1.0mg/day dose. Median follow up of patients was:
11.5± 4.13 months (1.0mg dose) and 9.25± 4.78 months
(0.5mg dose). Four of six patients (66%) who received
1mg/day Entecavir, developed resistance over a median
follow up of 11 months. Of the four patients who received
0.5mg/day entecavir, one (25%) developed resistance over
follow up of 15 months.
Conclusions: Entecavir therapy in Lam resistant CHB
patients was associated with a high rate of inadequate
viral suppression and development of resistance. The dose
of Entecavir (0.5 or 1.0) did not seem to have much effect
in this group of patients.
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Background: Resistance to CHB antivirals is a challenge
in the long term. Clinical beneﬁts are compromised once
resistance develops and cross-resistance limits treatment
options.
Methods: Current study randomly selected 575 CHB-treating
physicians from China, South Korea, Taiwan, and Thailand
where HBV infection is a substantial clinical and ﬁnancial
burden. The study comprised two components designed to
assess: (1) current practice in diagnosing antiviral resistance
and its management; and (2) ﬁnancial impact of managing
“suspected” resistance.
Results: 95 100% of interviewed physicians had encountered
antiviral resistance in the ﬁrst-line setting. Although 68%
agreed that prevention of resistance is the most important
strategy, 5% did not consider resistance a critical issue.
While direct antiviral resistance tests are readily available
in South Korea, access is limited in most Asian countries.
DNA and ALT tests are the common parameters used
to identify suspected resistance in China, Taiwan, and
Thailand. Management of suspected resistance (drug cost
not included) costs an additional USD 709, 580, 572 and 329
in South Korea, China, Taiwan and Thailand respectively,
during the ﬁrst year immediately after it is identiﬁed.
Conclusion: Antiviral resistance is a major concern among
physicians in Asia, especially during long-term therapy.
While access to direct resistance testing is limited in most
countries, indirect methods are widely used to guide CHB
management decisions. In choosing an oral antiviral to
initiate therapy, resistance proﬁle of antiviral is a crucial
factor to consider since drug resistance compromises clinical
beneﬁt and incurs additional cost.
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Objective: The aim of this study is to investigate the
viral and host factors of metabolic syndrome in chronic
hepatitis B patients.
Methods: We studied 89 patients with untreated chronic
hepatitis B, who were from Beijing Ditan hospital in 2005 to
2007. According to the diagnose of metabolic syndrome, two
groups were established: group with MS (+MS) and group MS
( MS).They were compared with demographic, biochemical,
metabolic and histological characteristics.
Results: The mean age, BMI and gender were not
statistically signiﬁcant difference (p > 0.05) between the
two groups. In the group of chronic hepatitis B with MS,
the levels of FINS, HOMA-IR, HOMA-b, TG, and the positivity
of HBeAg were signiﬁcantly higher than those in the group
without MS (P< 0.05. The degree of hepatosteasis in the
group with MS is signiﬁcantly more severe than that in the
group without MS (P< 0.001).
Conclusion: Metabolic syndrome in chronic hepatitis B
patients is closely correlated with insulin resistance and
glycometabolism, and less effect of viruses. That may be the
main characteristic of metabolism in patients chronically
infected with the hepatitis B virus.
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Objective: This paper is an attempt to do research on
the cloning characteristics of the CDR3-distinct of the TCR
Vbgene of the CD8+T cell of the HBV infected person.
Methods: The PCR approach of poly-primer is applied and
meanwhile the many pieces of the CDR3-distinct of the TCR
Vb gene are ampliﬁed. HR-Agarose Gel Electrophoresis is
employed to detect the cloning characteristics.
Result: The HBV infected person’s cloning of the TCR Vb9
and Vb14 of the CD8+T cell is obviously higher than the
normal control group (p < 0.01).
Conclusion: The HBV infected person has the cloning
changes of the TCR VbandVb14 of the CD8+T cell, which
have an effect on the mediating of the Liver Injury.
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HIV/AIDS is one of the most public health problems of
this century. Moreover, co-infection with the Hepatitis B
virus is likely to become a major health care catastrophe.
This study was carried out White Feather Nepal and
different 4 Laboratories with the objective to determine
HIV/Hepatitis B co-infection among 544 sexual minorities
from Katmandu including Men Sex workers, gay men and
transgender.
Methods: HIV status was determined both by Rapid and
ELISA techniques. HIV sero-positive samples were further
tested for Hepatitis B Surface Antigen (HBsAg) by ELISA.
Data obtained from laboratories ﬁndings and questionnaires
were statistically analyzed by using SPSS 11.5.
Results: Out of 544 HIV suspected individuals, 221 (40%)
were diagnosed as HIV positive, of which, 187 HIV positive
sera were tested for Hepatitis B. In HIV positive individuals,
sexual transmission was the most common route (77.4%),
followed by IDUs (12.2%). Of 187 HIV positive individuals,
15% were diagnosed to be co-infected with Hepatitis B.
Highest prevalence of HIV/Hepatitis B co-infection (46.4%)
was observed in age group 26 35 years, followed by 16 25
years and the co infection rate was found to be higher
(78.6%) in married individuals than in unmarried (17.9%).
Lower rate of co-infection (17.9%) was detected among the
individuals vaccinated against Hepatitis B than unvaccinated
(82.1%).
